Cinnatropin 30IU 10mg somatropin pen by Cinagen - original packaging

CINNATROPIN 30 IU (10 mg) is a recombinant Human Growth Hormone [somatropin rDNA origin] delivered via a precision-engineered injectable pen device. The pen system incorporates a lyophilized powder and sterile injection solution in separate compartments, with an integrated mixing mechanism activated prior to administration. Cinnatropin is available for clinical and research use in Thailand and internationally.

✔ Key Research Insights

Studied for its role in stimulating IGF-1 production in the liver, with downstream effects on cellular growth and regeneration documented in research literature
Investigated for its influence on immune system function in research subjects across documented observations
Examined for its effects on metabolic processes, including fat oxidation and lean mass parameters in subject populations
Documented in endocrinological literature for its relevance to growth hormone deficiency research across pediatric and adult study populations
Researched for its effects on tissue maintenance and repair, including musculoskeletal and organ-level regeneration, in documented subject populations
Studied for its influence on post-injury recovery and metabolic rate in research settings
Delivered as a ready-to-use liquid formulation for consistent, standardized administration in research protocols

📦 Product Specifications

Product: CINNATROPIN
Molecule: Somatropin (rDNA origin) — 191 amino acid sequence
Concentration: 30 IU / 10 mg
Form: Lyophilized powder with sterile solvent, pre-filled injectable pen
Administration: Subcutaneous injection
Dosage considerations may vary. Consulting a qualified professional is recommended.

⚙ How It Works
Somatropin is a recombinant DNA-derived human growth hormone consisting of a 191-amino acid chain identical in structure to endogenous pituitary-derived HGH. Due to its peptide nature, somatropin is not orally bioavailable, as gastric acid degrades the molecule prior to systemic absorption; subcutaneous or intramuscular injection is therefore the required route of administration in all documented clinical protocols. Following injection in research subjects, somatropin acts on hepatic receptors to stimulate the production of insulin-like growth factor 1 (IGF-1), the primary downstream mediator of growth hormone activity throughout the body. Documented effects in clinical literature include influences on bone and muscle development, tissue repair and regeneration, metabolic regulation, and immune function. The Cinnatropin pen device facilitates accurate dosing through its pre-filled, ready-to-use liquid formulation, engineered for consistent stability and precise measurement at the point of administration

⭐ Product Overview

Precision-engineered injectable pen with integrated lyophilized powder and sterile solvent compartments for consistent pre-administration mixing
Recombinant DNA-derived somatropin formulation with a 191-amino acid sequence identical to endogenous human growth hormone
Clinically established compound with documented indications across pediatric and adult growth hormone deficiency, wasting conditions, and metabolic disorders
Pharmaceutical-grade manufacturing standards ensuring compound purity, potency, and stability

Cinnatropin 30IU (10mg) — Somatropin HGH Pen (Cinagen)

THB 5,250.00

THB 3,500.00

Quantity

The Cinnatropin pen contains 1.5ml of sterile solution, delivering a total of 30 IU across its dial. The dial is graduated up to 150 units, with each measurement corresponding to a specific IU value. Reference points on the dial: 10 clicks = 2 IU, 15 clicks = 3 IU, 20 clicks = 4 IU, 40 clicks = 8 IU, 60 clicks = 12 IU, 80 clicks = 16 IU. This graduated system is engineered to allow precise, standardized measurement in research and clinical administration contexts.